P. D. Beer et al.
1.32 ppm (s, 36H; tBu); 13C{1H} NMR (75.5 MHz, CDCl3): d=166.9,
158.6, 152.9, 151.7, 148.6, 146.8, 145.0, 144.4, 143.3, 134.5, 133.9, 131.9,
131.6, 131.0, 130.6, 129.0, 127.4, 125.8, 124.3, 123.5, 119.8, 115.9, 114.7,
70.6, 70.4, 70.0, 67.5, 66.9, 63.8, 49.3, 39.7, 34.3, 31.3 ppm; 19F{1H} NMR
(282.4 MHz, CDCl3): d=ꢀ70.0 ppm (d, 1J=710 Hz, PF6ꢀ); 31P{1H} NMR
(121.6 MHz, CDCl3): d=ꢀ144.0 ppm (sept, 1J=710 Hz, PF6ꢀ); HRMS
(ESI): m/z: calcd for C106H116N5O11: 1635.8699; found: 1635.8691
[MꢀPF6]+.
19F{1H} NMR (282.4 MHz 1:1 CDCl3/CD3OD): d=ꢀ74.5 ppm (d, 1J=
710 Hz, PF6ꢀ); 31P{1H} NMR (121.6 MHz, 1:1 CDCl3/CD3OD): d=
ꢀ143.7 ppm (sept, 1J=710 Hz, PF6ꢀ); HRMS (ESI): m/z: calcd for
C104H112N5O10: 1591.8443; found: 1591.8391 [MꢀPF6]+.
Rotaxane 8·Cl (method 1): BisACHTNUTRGNE(NUG amine) 3 (46 mg, 0.093 mmol) and 3,5-
pyridine dicarbonyl dichloride (16 mg, 0.093 mmol) were used. Prepara-
tive TLC (silica; 9:1 CHCl3/MeOH) gave a yellow solid (55 mg, 36%).
1H NMR (300 MHz, 1:1 CDCl3/CD3OD): d=9.58 (s, 1H; pyridinium H4),
9.51 (s, 2H; pyridinium H2 & H6), 9.25 (t, 4J=2.1 Hz, 1H; pyridine H4),
9.09 (d, 4J=2.1 Hz, 2H; pyridine H2, H6), 7.68 (d, 3J=8.8 Hz, 4H;
HNArH), 7.26–7.03 (m, 30H; ArH), 6.42 (d, 3J=9.1 Hz, 4H; hydroqui-
Rotaxane 6·Cl (method 1): BisACTHUNRTGNEUNG(amine) 2 (60 mg, 0.093 mmol) and 5-nitro-
isophthaloyl dichloride (23 mg, 0.093 mmol) were used. Preparative TLC
(silica; 93:7 CHCl3/MeOH) gave a yellow solid (87 mg, 55%). 1H NMR
(300 MHz, CDCl3): d=10.27 (s, 2H; axle NH), 10.02 (s, 1H; pyridinium
H4), 9.37 (s, 1H; isophthalamide H4), 8.99 (s, 2H; isophthalamide H2,
none ArH), 6.13 (d, 3J=9.1 Hz, 4H; hydroquinone ArH), 4.56 (s, 3H;
3
N+CH3), 4.06 (t, J=4.6 Hz, 4H; CH2 ), 3.90–3.86 (m, 12H; CH2 ),
ꢀ
ꢀ
ꢀ
ꢀ
3.66 (t, J=4.6 Hz, 4H; CH2 ), 1.29 ppm (s, 36H; tBu); 13C{1H} NMR
(75.5 MHz, 1:1 CDCl3/CD3OD): d=166.5, 159.8, 153.7, 152.8, 152.6,
149.5, 147.8, 145.9, 144.5, 139.0, 135.5, 134.8, 133.6, 132.6, 131.8, 131.5,
129.4, 128.3, 126.7, 125.2, 121.6, 115.5, 114.8, 71.7, 71.0, 68.1, 66.4, 64.8,
3
4
3
H6), 8.91 (d, J=1.2 Hz, 2H; pyridinium H2, H6), 8.68 (t, J=3.8 Hz, 2H;
isophthalamide NH), 7.86 (d, 3J=8.8 Hz, 4H; ArHNH), 7.26–6.99 (m,
30H; ArH), 6.47 (d, 3J=9.1 Hz, 4H; hydroquinone ArH), 6.17 (d, 3J=
9.1 Hz, 4H; hydroquinone ArH), 4.71 (s, 3H; N+CH3), 4.13 (t, 3J=
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
41.6, 35.0, 31.9, 30.5 ppm; HRMS (ESI): m/z: calcd for C103H111N6O10
:
4.7 Hz, 4H; CH2 ), 3.77–3.72 (m, 20H; CH2 ), 1.32 ppm (s, 36H;
tBu); 13C{1H} NMR (75.5 MHz, CDCl3): d=158.0, 153.3, 151.8, 148.5,
146.7, 145.3, 144.8, 143.3, 137.1, 135.2, 134.7, 133.6, 131.8, 130.9, 130.5,
130.0, 127.3, 126.4, 125.8, 124.2, 120.3, 114.7, 70.7, 70.5, 70.0, 68.4, 65.4,
63.7, 49.8, 41.0, 34.3, 31.3 ppm; HRMS (ESI): m/z: calcd for
C106H116N6O13: 1680.8556; found: 1680.8631 [MꢀCl]+.
1592.8395; found: 1592.7850 [MꢀCl]+.
Rotaxane 8·PF6 (general procedure for anion exchange): By using rotax-
ane 8·Cl (50 mg, 0.031 mmol) to give 8·PF6 as a yellow solid (53 mg,
100%). 1H NMR (300 MHz, 1:1 CDCl3/CD3OD): d=9.36 (s, 2H; pyridi-
4
nium H2, H6), 9.10 (d, J=2.1 Hz, 2H; pyridine H2, H6), 9.06 (s, 1H; pyri-
dinium H4), 9.00 (t, 4J=2.1 Hz, 1H; pyridine H4), 7.55 (d, 3J=8.8 Hz,
Rotaxane 6·PF6 (general procedure for anion exchange): By using rotax-
ane 6·Cl (75 mg, 0.044 mmol) to give 6·PF6 as a yellow solid (80 mg,
3
4H; HNArH), 7.26–7.06 (m, 30H; ArH), 6.43 (d, J=9.1 Hz, 4H; hydro-
3
1
quinone ArH), 6.22 (d, J=9.1 Hz, 4H; hydroquinone ArH), 4.58 (s, 3H;
100%). H NMR (300 MHz, CDCl3): d=9.93 (brs, 2H; axle NH), 8.97 (s,
+
3H; pyridinium H2, H4, H6), 8.65 (s, 2H; isophthalamide H2, H6), 8.51 (s,
ꢀ
ꢀ
ꢀ
ꢀ
N CH3), 3.94 (brs, 4H; CH2 ), 3.89–3.87 (m, 12H; CH2 ), 3.55 (brs,
4H; CH2 ), 1.29 ppm (s, 36H; tBu); 13C{1H} NMR (75.5 MHz, 1:1
CDCl3/CD3OD): d=166.4, 159.5, 153.43, 152.4, 151.8, 149.4, 147.7, 147.4,
146.1, 144.3, 141.1, 135.2, 133.7, 132.6, 131.7, 131.4, 130.1, 128.2, 126.7,
125.1, 121.4, 115.6, 114.8, 71.4, 70.9, 68.0, 66.7, 64.7, 40.4, 35.0, 31.8 ppm;
19F{1H} NMR (282.4 MHz, 1:1 CDCl3/CD3OD): d=ꢀ73.0 ppm (d, 1J=
712 Hz, PF6ꢀ); 31P{1H} NMR (121.6 MHz, 1:1 CDCl3/CD3OD): d=
ꢀ144.2 ppm (sept, 1J=712 Hz, PF6ꢀ); HRMS (ESI): m/z: calcd for
1H isophthalamide H4), 7.65 (d, J=8.5 Hz, 4H; ArHNH), 7.28–7.07 (m,
2
ꢀ
ꢀ
32H; ArH, isophthalamide NH), 6.64 (d, 2J=8.1 Hz, 4H; hydroquinone
ArH), 6.35 (d, 2J=8.1 Hz, 4H; hydroquinone ArH), 4.06–4.03 (m, 7H;
+
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
N CH3, CH2 ), 3.75–3.70 (m, 16H; CH2 ), 3.57 (brs, 4H; CH2 ),
1.32 ppm (s, 36H; tBu); 13C{1H} NMR (75.5 MHz, CDCl3): d=164.5,
158.8, 153.0, 151.6, 148.7, 146.7, 145.2, 144.6, 143.3, 136.1, 134.5, 134.0,
132.0, 131.0, 130.5, 127.4, 126.3, 125.9, 124.3, 119.8, 115.9, 114.7, 70.6,
70.5, 70.1, 67.3, 66.7, 63.8, 49.4, 39.9, 34.3, 31.3 ppm; 19F{1H} NMR
(282.4 MHz, CDCl3): d=ꢀ70.0 ppm (d, 1J=713 Hz, PF6ꢀ); 31P{1H} NMR
(121.6 MHz, CDCl3): d=ꢀ144.0 ppm (sept, 1J=713 Hz, PF6ꢀ); HRMS
C
103H111N6O10: 1592.8395; found: 1592.8319 [MꢀPF6]+.
Rotaxane 9·Cl (method 1): BisACTHUNRTGNEUNG(amine) 3 (46 mg, 0.093 mmol) and 5-nitro-
isophthaloyl dichloride (23 mg, 0.093 mmol) were used. Preparative TLC
(silica; 93:7 CHCl3/MeOH) gave a yellow solid (64 mg, 41%). 1H NMR
(300 MHz, 1:1 CDCl3/CD3OD): d=9.62 (s, 1H; pyridinium H4), 9.52 (s,
2H; pyridinium H2, H6), 9.30 (brt, 4J=1.4 Hz, 1H; isophthalamide H2),
(ESI): m/z: calcd for C106H116N6O13
[MꢀPF6]+.
: 1680.8556; found: 1680.8534
Rotaxane 7·Cl (method 1): BisACHTNUTRGNE(NUG amine) 3 (46 mg, 0.093 mmol) and iso-
4
3
8.84 (d, J=1.4 Hz, 2H; isophthalamide H4, H6), 7.72 (d, J=8.7 Hz, 4H;
phthaloyl dichloride (19 mg, 0.093 mmol) were used. Preparative TLC
(silica; 9:1 CHCl3/MeOH) gave a yellow solid (62 mg, 42%). 1H NMR
(300 MHz, 1:1 CDCl3/CD3OD): d=9.58 (s, 1H; pyridinium H4), 9.46 (s,
2H; pyridinium H2, H6), 8.80 (t, 4J=1.5 Hz, 1H; isophthalamide H2),
7.95 (dd, 3J=7.9, 4J=1.5 Hz, 2H; isophthalamide H4, H6) 7.68 (d, 3J=
8.7 Hz, 4H; ArHNH), 7.25–7.05 (m, 31H; ArH, isophalamide H5), 6.38
HNArH), 7.25–6.99 (m, 30H; ArH), 6.42 (d, 3J=9.1 Hz, 4H; hydroqui-
none ArH), 6.13 (d J=9.1 Hz, 4H; hydroquinone ArH), 4.58 (s, 3H; N+
3
3
ꢀ
ꢀ
ꢀ
ꢀ
CH3), 4.10 (t, J=4.4 Hz, 4H; CH2 ), 3.89–3.84 (m, 12H; CH2 ), 3.69
(t, 3J=4.4 Hz, 4H; CH2
)
1.30 ppm (s, 36H; tBu); 13C{1H} NMR
ꢀ
ꢀ
(75.5 MHz, 1:1 CDCl3/CD3OD): d=165.7, 159.4, 153.6, 152.6, 149.3,
149.2, 147.5, 144.1, 135.8, 135.2, 133.4, 132.4, 131.6, 131.2, 128.0, 126.9,
126.5, 124.9, 121.2, 115.3, 114.6, 71.5, 70.9, 67.9, 66.1, 64.5, 41.8, 34.9, 31.8,
30.3 ppm; HRMS (ESI): m/z: calcd for C106H114N7O12: 1636.8394; found:
1636.7740 [MꢀCl]+.
(d, 3J=9.0 Hz, 4H; hydroquinone ArH), 6.11 (d, 3J=9.0 Hz, 4H; hydro-
quinone ArH), 4.44 (s, 3H; N+CH3), 4.08 (t, J=4.7 Hz, 4H; CH2 ),
3
ꢀ
ꢀ
3
ꢀ
ꢀ
ꢀ
ꢀ
3.88–3.85 (m, 12H; CH2 ), 3.67 (t, J=4.7 Hz, 4H; CH2 ), 1.29 ppm
(s, 36H; tBu); 13C{1H} NMR (75.5 MHz, 1:1 CDCl3/CD3OD): d=168.9,
159.5, 153.7, 152.5, 149.3, 147.7, 145.5, 144.4, 139.6, 135.5, 134.2, 133.5,
132.4, 132.1, 131.7, 131.4, 129.6, 128.1, 126.5, 125.0, 121.1, 115.3, 114.7,
71.6, 70.9, 67.9, 66.3, 64.6, 41.3, 34.9, 31.8, 30.3 ppm; HRMS (ESI): m/z:
calcd for C104H112N5O10: 1591.8443; found: 1591.7578. [MꢀCl]+.
Rotaxane 9·PF6 (general procedure for anion exchange): By using rotax-
ane 9·Cl (50 mg, 0.030 mmol) to give 9·PF6 as a yellow solid (53 mg,
100%). 1H NMR (300 MHz, 1:1 CDCl3/CD3OD): d=9.41 (s, 2H; pyridi-
nium H2, H6), 9.15 (s, 1H; pyridinium H4), 9.06 (s, 1H; isophthalamide
H2), 8.84 (s, 2H; isophthalamide H4, H6), 7.57 (d, 3J=8.8 Hz, 4H;
HNArH), 7.25–7.03 (m, 30H; ArH), 6.43 (d, 3J=8.4 Hz, 4H; hydroqui-
Rotaxane 7·PF6 (general procedure for anion exchange): By using rotax-
ane 7·Cl (50 mg, 0.031 mmol) to give 7·PF6 as a yellow solid (53 mg,
100%). 1H NMR (300 MHz, 1:1 CDCl3/CD3OD): d=9.91 (s, 2H; pyridi-
nium NH), 9.27 (s, 2H; pyridinium H2, H6), 9.04 (s, 1H; pyridinium H4),
8.50 (s, 1H; isophthalamide H2), 8.10 (brs, 2H; isophthalamide NH), 7.94
none ArH), 3.97–3.58 (d, 3J=8.4 Hz, 4H; hydroquinone ArH), 4.59 (s,
+
ꢀ
ꢀ
ꢀ
ꢀ
3H; N CH3), 3.97 (brs, 4H; CH2 ), 3.89–3.87 (m, 12H; CH2 ), 3.58
(brs, 4H; CH2 ), 1.30 ppm (s, 36H; tBu); 13C{1H} NMR (125 MHz, 1:1
CDCl3/CD3OD): d=165.5, 159.2, 153.5, 152.4, 149.1, 147.4, 145.4, 144.0,
135.7, 135.1, 133.3, 132.2, 131.5, 131.1, 129.0, 127.9, 126.8, 126.3, 124.8,
121.0, 115.2, 114.4, 71.4, 70.7, 69.7, 66.0, 64.3, 53.5, 41.7, 34.7, 31.7 ppm;
19F{1H} NMR (282.4 MHz, 1:1 CDCl3/CD3OD): d=ꢀ73.0 ppm (d, 1J=
712 Hz, PF6ꢀ); 31P{1H} NMR (121.6 MHz, 1:1 CDCl3/CD3OD): d=
ꢀ144.0 ppm (sept, 1J=712 Hz, PF6ꢀ); HRMS (ESI): m/z: calcd for
C106H114N7O12: 1636.8394; found: 1636.8242 [MꢀPF6]+.
ꢀ
ꢀ
4
3
(dd, 3J=7.9, J=1.6 Hz, 2H; isophthalamide H4, H6), 7.51 (d, J=8.8 Hz,
4H; ArHNH), 7.39 (t, J=7.9 Hz, 1H; isophthalamide H5), 7.26–7.06 (m,
3
30H; ArH), 6.43 (d, 3J=9.1 Hz, 4H; hydroquinone ArH), 6.22 (d, 3J=
9.1 Hz, 4H; hydroquinone ArH), 4.51 (s, 3H; N+CH3), 3.94 (t, 3J=
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
4.6 Hz, 4H; CH2 ), 3.88–3.87 (m, 12H; CH2 ), 3.59–3.54 (m, 4H;
CH2 ), 1.29 ppm (s, 36H; tBu); 13C{1H} NMR (75.5 MHz, 1:1 CDCl3/
CD3OD): d=168.4, 159.2, 153.4, 152.2, 149.1, 147.5, 145.4, 144.1, 135.1,
134.1, 133.5, 132.3, 131.6, 131.2, 129.4, 127.9, 126.4, 125.3, 124.9, 121.5,
120.8, 115.2, 114.6, 71.3, 70.7, 67.7, 66.3, 64.4, 40.8, 34.8, 31.7 ppm;
ꢀ
Rotaxane 10·
ACHTNUGTNERN(UGN PF6)2: Rotaxane 8·PF6 (50 mg, 0.030 mmol) was dissolved
in MeI (5 mL) and the solution was heated at reflux under a nitrogen at-
13092
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 13082 – 13094